Related Experiment Video
Updated: Dec 21, 2025

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers
Published on: March 1, 2024
Dysregulation in nucleic acid-sensing pathway genes is associated with cancer patients' prognosis
Huo Yan-Fei1, Yang Han1, Zhou Yan-Ting1
1Department of Pathology, School of Basic Medical Sciences, Third Hospital, Peking University Health Science Center, Beijing, China.
Abstract:
The innate immune system, the first line of defense against pathogens, is activated by nucleic acids from microbial invaders that are recognized by nucleic acid-sensing receptors. Recent evidence affirms the ability of these receptors to respond to nucleic acids released by damaged cancer cells. The innate immune system is also involved in cancer immunosurveillance, and could be modulated for devising effective antitumor therapies by targeting nucleic acid-sensing pathways. A systematic, comprehensive analysis of dysregulation in nucleic acid-sensing pathways in cancer is required to fully understand its role. Based on multidimensional data of The Cancer Genome Atlas pan-cancer cohort, we revealed that upregulation of cytosolic DNA-sensing genes like AIM2 and CGAS was common in tumor tissues. We used 15 genes in the nucleic acid-sensing pathway to cluster all tumor patients into 2 subgroups and found that the subgroup with higher expression of nucleic acid-sensing pathway genes was associated with poorer prognosis across cancer types. However, in homologous recombination deficient patients, the nucleic acid recognition activated subgroup was associated with better prognosis, which confirms the therapeutic effect of nucleic acid recognition. This study contributes to a better understanding of the functions and mechanisms of nucleic acid recognition in cancer, lays the foundation for new therapeutic strategies, and enlarges the scope of development of new drugs.
Insights
The innate immune system recognizes nucleic acids from microbes and damaged cancer cells. Upregulated nucleic acid-sensing pathways are linked to poorer cancer prognosis, but offer therapeutic potential in specific patient groups.
Area of Science:
- Immunology
- Oncology
- Genomics
Background:
- The innate immune system uses nucleic acid-sensing receptors to detect microbial invaders.
- These receptors also recognize nucleic acids released by damaged cancer cells, linking innate immunity to cancer.
- Targeting nucleic acid-sensing pathways offers potential for novel antitumor therapies.
Purpose of the Study:
- To systematically analyze the dysregulation of nucleic acid-sensing pathways in cancer.
- To understand the prognostic implications of these pathways in a pan-cancer cohort.
- To explore the therapeutic potential of nucleic acid recognition in cancer treatment.
Main Methods:
- Utilized multidimensional data from The Cancer Genome Atlas (TCGA) pan-cancer cohort.
- Analyzed the expression of 15 key genes in the nucleic acid-sensing pathway.
- Clustered cancer patients into subgroups based on gene expression for prognostic analysis.
Main Results:
- Upregulation of cytosolic DNA-sensing genes (e.g., AIM2, cGAS) is common in tumor tissues.
- Higher expression of nucleic acid-sensing pathway genes correlates with poorer prognosis across most cancer types.
- In homologous recombination deficient (HRD) patients, activated nucleic acid recognition is associated with better prognosis, suggesting therapeutic efficacy.
Conclusions:
- Dysregulation of nucleic acid-sensing pathways plays a significant role in cancer development and progression.
- Prognostic and therapeutic implications of these pathways vary depending on cancer type and patient genetic background (e.g., HRD status).
- This research provides a foundation for developing targeted nucleic acid-based cancer therapies and drugs.
More Related Videos
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
Abnormal Proliferation
Biosynthesis of Nucleic Acids
The Nucleolus

